CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Pfizer (PFE) Advances Tilrekimig After Positive Phase 2 Atopic Dermatitis Results

Phase 2positiveTilrekimigPositive
AI Analysis

Summary

Pfizer advanced tilrekimig development following positive Phase 2 results in atopic dermatitis. The positive data supports progression of the program.

Clinical Trial Data

Phase

2

Primary Endpoint

Met

Importance:7/10
Sentiment:
0.70
Phase 2Atopic DermatitisClinical TrialPositive Data
Related Companies

Read the original article

Published by yahoo_finance on October 1, 2026 6:09 PM

Read Original